Zajac JM - Search Results

1

Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists.

Mollereau C, Mazarguil H, Marcus D, Quelven I, Kotani M, Lannoy V, Dumont Y, Quirion R, Detheux M, Parmentier M, Zajac JM. Mollereau C, et al. Among authors: zajac jm. Eur J Pharmacol. 2002 Sep 20;451(3):245-56. doi: 10.1016/s0014-2999(02)02224-0. Eur J Pharmacol. 2002. PMID: 12242085

2

Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.

Quelven I, Roussin A, Burlet-Schiltz O, Gouardères C, Tafani JA, Mazarguil H, Zajac JM. Quelven I, et al. Among authors: zajac jm. Eur J Pharmacol. 2002 Aug 2;449(1-2):91-8. doi: 10.1016/s0014-2999(02)01983-0. Eur J Pharmacol. 2002. PMID: 12163111

3

Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells.

Mollereau C, Mazarguil H, Zajac JM, Roumy M. Mollereau C, et al. Among authors: zajac jm. Mol Pharmacol. 2005 Mar;67(3):965-75. doi: 10.1124/mol.104.004614. Epub 2004 Dec 17. Mol Pharmacol. 2005. PMID: 15608144

4

Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.

Quelven I, Roussin A, Zajac JM. Quelven I, et al. Among authors: zajac jm. Eur J Pharmacol. 2005 Jan 31;508(1-3):107-14. doi: 10.1016/j.ejphar.2004.12.002. Epub 2005 Jan 7. Eur J Pharmacol. 2005. PMID: 15680260

5

Characterization of two novel tritiated radioligands for labelling Neuropeptide FF (NPFF(1) and NPFF(2)) receptors.

Talmont F, Garcia LP, Mazarguil H, Zajac JM, Mollereau C. Talmont F, et al. Among authors: zajac jm. Neurochem Int. 2009 Dec;55(8):815-9. doi: 10.1016/j.neuint.2009.08.004. Epub 2009 Aug 12. Neurochem Int. 2009. PMID: 19682524

6

Study of the N-terminal part of peptidic selective NPFF₂ agonists.

Mazarguil H, Mollereau C, Czaplicki G, Zajac JM. Mazarguil H, et al. Among authors: zajac jm. Peptides. 2012 Sep;37(1):157-60. doi: 10.1016/j.peptides.2012.07.008. Epub 2012 Jul 16. Peptides. 2012. PMID: 22813580

7

Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226.

Mollereau C, Gouardères C, Dumont Y, Kotani M, Detheux M, Doods H, Parmentier M, Quirion R, Zajac JM. Mollereau C, et al. Among authors: zajac jm. Br J Pharmacol. 2001 May;133(1):1-4. doi: 10.1038/sj.bjp.0704049. Br J Pharmacol. 2001. PMID: 11325787 Free PMC article.

8

Functional characterization of a human receptor for neuropeptide FF and related peptides.

Kotani M, Mollereau C, Detheux M, Le Poul E, Brézillon S, Vakili J, Mazarguil H, Vassart G, Zajac JM, Parmentier M. Kotani M, et al. Among authors: zajac jm. Br J Pharmacol. 2001 May;133(1):138-44. doi: 10.1038/sj.bjp.0704038. Br J Pharmacol. 2001. PMID: 11325803 Free PMC article.

9

Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [(125I]EYF as selective radioligands.

Gouardères C, Quelven I, Mollereau C, Mazarguil H, Rice SQ, Zajac JM. Gouardères C, et al. Among authors: zajac jm. Neuroscience. 2002;115(2):349-61. doi: 10.1016/s0306-4522(02)00419-0. Neuroscience. 2002. PMID: 12421602

10

Opioid-modulating peptides: mechanisms of action.

Mollereau C, Roumy M, Zajac JM. Mollereau C, et al. Among authors: zajac jm. Curr Top Med Chem. 2005;5(3):341-55. doi: 10.2174/1568026053544515. Curr Top Med Chem. 2005. PMID: 15857316 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters